Welcome Guest | Register / Login

Global Asthma & COPD Market Report: 2015 Edition

Table of Contents

1. Overview
1.1 Definition of Asthma
1.2 Types of Asthma
1.3 Triggers of Asthma
1.4 Treatment Options for Asthma
1.5 Chronic Obstructive Pulmonary Disease (COPD)
1.5.1 Difference between Asthma and COPD
1.5.2 Treatment Options for COPD

2. Market Analysis
2.1 Global Respiratory Market
Market Value
Market Segments
Regional Breakdown
2.1.1 Global Respiratory Therapeutics Market
Market Value
Product Segmentation
2.1.2 Global Inhalation Drug Delivery Technologies Market
Market Value
Product Segmentation
2.2 Global Asthma/COPD Market
Market Value
Prevalence Rate
Regional Breakdown
2.2.1 Global Asthma/COPD Therapeutics Market
2.3 Global Severe Asthma Market

3. Regional Markets
3.1. The U.S.
Market Overview
Diagnosed/Treated Population
3.2 European Union
Market Overview
Diagnosed/Treated Population

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Global Spending on Medicines
4.1.2 Cigarette and Tobacco Consumption
4.1.3 Rising Prevalence of Non Communicable Diseases
4.1.4 Increasing Use of Biologic Drugs
4.1.5 Escalating Global GDP
4.1.6 Global Healthcare Expenditure
4.2 Key Trends and Developments
4.2.1 Launch of New Severe Asthma Drugs
4.2.2 Introduction of New COPD Drugs
4.3 Challenges
4.3.1 Increased Pricing Pressure
4.3.2 Patent Expiries and Generic Drugs

5. Competitive Landscape
5.1 Global Respiratory Market
5.2 Global Severe Asthma Market

6. Company Profiles
6.1 AstraZeneca
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Merck and Co.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Roche
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Sanofi
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Novartis
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies  

List of Tables

Common Asthma Triggers
Distinguishing Feature of Asthma and COPD
Treatment Guidelines for COPD
Investigational Treatment for Severe Asthma
Selective New Drugs for COPD
Global Respiratory Market by Company (2011-2015E)

List of Charts

Treatment Guidelines for Asthma
Global Respiratory Market (2012-2018E)
Global Respiratory Market by Conditions (2014E)
Global Respiratory Market by Regions (2014E)
Global Respiratory Therapeutics Market (2010-2015E)
Global Respiratory Market by Drugs (2014E)
Global Inhaled Maintenance Respiratory Market by Value (2008-2025E)
Global Inhaled Maintenance Respiratory Market Volume by Prescription Equivalents (2008-2025E)
Global Inhalation Drugs Delivery Technologies Market (2013-2018E)
Global Inhalation Drug Delivery Technology by Products (2014)
Global Active Asthma Prevalence, Diagnosed and Treated Population (2014)
Global Asthma Market by Value (2012-2022E)
Global COPD Prevalence Rate by Countries (2014)
Global COPD Severity by Country (2014)
Global COPD Market by Value (2012-2022E)
Global Asthma/COPD Market by Region (2017E)
Global Asthma/COPD Therapeutic Market (2010-2015E)
Global Severe Asthma Biologics Market Forecast (2013-2022E)
Global Severe Asthma Biologics Market by Drugs (2022E)
The U.S. Asthma Diagnosed Population (2015E-2025E)
The U.S. Asthma Treated Population (2015E-2025E)
The U.S. PRS-080 Product Market and Penetration Rate (2021-2025E)
EU Asthma Diagnosed Population (2015E-2025E)
EU Asthma Treated Population (2015-2025E)
EU PRS-080 Product Market and Penetration Rate (2022-2025E)
Global Spending on Medicines (2007-2017E)
Global Cigarettes Consumption (1910-2014)
Global Deaths Occurred by NCDs by Region (2012)
Global Biologics Market (2008-2014E)
Global Gross Domestic Product Growth (2009-2014)
Global Healthcare Expenditure Per Capita (2009-2014E)
Global Respiratory Market Share by Company (2014)
Global Severe Asthma Market Share by Company (2022E)
AstraZeneca Revenue by Therapeutic Segment (2013/2014)
AstraZeneca Revenue by Regions (2013/2014)
AstraZeneca Revenue and Net profit (2010-2014)
AstraZeneca Pipeline Development Projects (2012-2014)
Merck and Co. Revenue by Segments (2013/2014)
Merck and Co. Revenue by Regions (2014)
Merck and Co. Revenue and Net Income (2010-2014)
Merck and Co. Research and Development Expenditure (2010-2014)
Roche’s Revenue by Business Segments (2014)
Roche’s Revenue and Net Income (2010-2014)
Sanofi Revenue by Segments (2013/2014)
Sanofi Revenue by Regions (2013/2014)
Sanofi Sales and Net Income (2010-2014)
Novartis Revenue by Business Segments (2014)
Novartis Revenues (2010-2014)

Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Corporate User License: Report will be emailed in PDF format and allows all employees within the organization to access it. This License type allows the report to be Printed.
Hard Copy: A printed copy of the report will be shipped.      This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Koncept Analytics
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy